News
Legal Updates
- March 26, 2020Under the conditions of coronavirus spread, the week from March 30 in Russia is declared as a non-working one with the preservation of salaries
- March 24, 2020Overview of changes in the international coronavirus pandemic. Сontinued
- March 20, 2020Overview of changes caused by international coronavirus pandemic
Recent Deals
Representing Japanese pharmaceutical company Santen in a dispute on debt recovery with a Russian distributor of medicines
Advising major international pharmaceuticals company Glenmark on several compliance issues, advertising law and activities aimed at promoting medical products on the Internet
Advising Japanese electronics company Sharp in a dispute with the Federal Tax Service (FTS) on the issue related to preliminary classification of a product and supplemental tax assessment
Legal support of the fund established by inheritors of the famous Tove Jansson in monitoring online and offline infringements and protecting their copyrights to Moomin characters in Russia
Business support measures under COVID-19 outbreak
The coronavirus outbreak (COVID-19) served as a trigger for a targeted effort to assess and manage the possible effects of it. While the threat of the spread is not on the decline, the Russian Government continues to update the measures taken or introduce new ones, trying to act ahead of the possible adverse consequences. We are closely monitoring the situation and put together an overview of the measures introduced in Russia caused by the COVID-19 outbreak
Overview of Decree Establishing Non-Working Week in Russia Due to COVID-19
Although the reasons for adopting the Decree are quite understandable, it is not clear how some of its provisions will be interpreted and applied. Experts of the Lidings Employment Law practice have put together an overview of the published Decree
Legal Digest | January 2020: Patent Disputes in Life Sciences (EAEU, CIS, Eastern Europe)
Heaving vast expertise in providing legal protection to large Russian and international pharmaceuticals and healthcare companies, Lidings has put together a Legal Digest highlighting the most notable patents disputes in Life Sciences
